Filing metadata

Accession number
0000899243-21-036769
Form type
Form 4
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
Sep 21, 2021
Reporting period
Sep 17, 2021
Description
Insider transaction

Explore SEC Filings Hub